Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy.

この研究はインパクトが大きい可能性があると判断されました。 OEのAIによるハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文の影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することができ、読者は将来の診療を形成する可能性が最も高い論文に焦点を当てることができます。

研究概要

Thirty-one patients with chronic insertional Achilles tendinopathy were randomized to receive low-energy extracorporeal shockwave therapy (ESWT) (n=16) or sham therapy (n=15). The primary outcome of interest was pain on a Visual Analogue Scale (VAS). The secondary outcome of interest was the VAS foot and ankle (VAS-FA) total score and pain, function and other complaints sub-scores. Additionally, the incidence of complications and rescue analgesic use. All outcomes were measured at 2, 3, 4, 6, 12, and 24 weeks post-treatment. The results revealed that VAS pain was statistically significantly improved from baseline at 4 to 12 weeks in the EWST group, and at 12 and 24-weeks in the Sham group (p<0.05 for all). Furthermore, VAS-FA pain sub-scores in the sham group were statistically significantly improved from baseline at both 12 and 24 weeks (p<0.05 for both). However, all other outcomes did not improve from baseline in either the EWST or control groups. Across all timepoints, no statistically significant difference was observed between the EWST and sham groups for all outcomes (p>0.05 for all).